With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.
Emirates to resume flights on Monday
UAE responds to incoming Iranian missile, drone threats on Monday
Dubai announces temporary suspension of flights
Dubai temporarily closes routes near airport
Fire contained in drone incident near Dubai Airport
UAE President and Saudi Crown Prince discuss regional developments
UAE Foreign Minister discusses regional tensions with global partners
UAE helps the return of 500 Golden Visa holders and residents stranded abroad
